The Research begins with the Overview of “Global Rosuvastatin Calcium Market” Analysing Industrial Chain, Sourcing Strategy and Downstream Buyers. The Research also provide Information about Manufacturers, Market Competition, Cost, Market Effect Factors with Market Forecast (2018-2023). This enables the buyer of the report to gain a telescopic view of the competitive landscape and plan the strategies accordingly.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
The worldwide market for Rosuvastatin Calcium is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 550 million US$ in 2023, from 430 million US$ in 2017.
Request for the sample copy: https://www.reporthive.com/enquiry.php?id=1584726&req_type=smpl
Market Segment by Manufacturers, this report covers
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm…And More
To Buy This Informative Research Report, Please click On the Link@ https://www.reporthive.com/enquiry.php?id=1584726&req_type=purch
Scope of the Report:
This report focuses on the Rosuvastatin Calcium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With the raw material advantage, EU is the dominate producer and exporter in rosuvastatin calcium industry. The production market share of EU has reached about 35.25% in 2015. In additional, EU is also the largest consumer of rosuvastatin calcium, about 34.47% of the global production was consumed in EU in 2015. China is the second producer with the market share of 28.82% in 2015. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55.09% of the total amount in 2015.
Market Segment by Type, covers
Purity 98.0%
Purity 99.0%
Other
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Applications, can be divided into
Tablet (including dispersible tablet and general tablet)
Capsule
Others
TABLES AND FIGURES
1 Market Overview
2 Manufacturers Profiles
3 Global Rosuvastatin Calcium Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
4 Global Rosuvastatin Calcium Market Analysis by Regions
5 North America Rosuvastatin Calcium by Countries
6 Europe Rosuvastatin Calcium by Countries…Toc Continued
About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.
Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
http://www.reporthive.com
Phone Number: +1-312 604 7084